CA
NZ
UK
AU
IND
US
American Healthcare REIT, Inc. announced the appointment of Gabriel M. Willhite as President and Chief Operating Officer, effective July 21, 2026. The company granted Willhite 6,038 restricted stock units as part of his appointment, which will vest over a three-year period contingent on his …
BofA Finance LLC, a subsidiary of Bank of America Corporation, has priced Digital Return Notes totaling $228 million that provide investors with conditional upside exposure tied to the performance of the Nasdaq-100, Russell 2000, and S&P 500 indices. The notes, which mature in approximately …
Groupon (NASDAQ: GRPN) shares moved higher, gaining 6.68% to $27.79, likely due to e-commerce and deal platform momentum, possible operational improvements, or sector rotation into consumer internet names.
Aurora Innovation (NASDAQ: AUR) shares advanced 5.94% to $6.69 on progress in autonomous vehicle technology, potential partnerships, testing updates, or broader autonomous vehicle and tech sector interest.
Liquidia Corporation (NASDAQ: LQDA) shares gained 5.92% to $85.68 on positive pipeline or regulatory momentum in its pulmonary hypertension or related programs.
VeriSign Inc. (NASDAQ: VRSN), the operator of the .com and .net domain registries, disclosed that board director Jamie S. Gorelick received an award of 900 restricted stock units on July 20, 2026. The grant vests immediately upon award date, subject to applicable tax withholding …
Forte Biosciences (NASDAQ: FBRX) shares gained 7.88% to $54.73 on positive biotech sentiment or company-specific developments in its dermatology or inflammatory pipeline.
Corsair Gaming (NASDAQ: CRSR) shares rose 7.70% to $10.64, a top gainer in the session, driven by gaming and hardware demand, new product momentum, or broader consumer tech sector strength.
EQT Corporation (NYSE: EQT) shares rose 7.53% to $53.55 after the company delivered strong Q2 results, with production beating guidance, a raised full-year production outlook, and lowered capital expenditure.
BioLife Solutions (NASDAQ: BLFS) shares advanced 7.45% to $31.37 on sector momentum or positive developments in its biopreservation and cell therapy support products.
Please wait processing your request...